An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 38
- Registration Number
- NCT04436471
- Locations
- 🇷🇺
Main military clinical hospital named after academician N. N. Burdenko, Moscow, Russian Federation
An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 38
- Registration Number
- NCT04437875
- Locations
- 🇷🇺
Sechenov First Moscow State Medical University, Moscow, Russian Federation
Study of Safety and Immunogenicity of BVRS-GamVac
- Conditions
- Interventions
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 162
- Registration Number
- NCT04130594
- Locations
- 🇷🇺
Research Institute of Influenza, Sankt-Peterburg, Russian Federation
Study of Safety and Immunogenicity of BVRS-GamVac-Combi
- Conditions
- Interventions
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 268
- Registration Number
- NCT04128059
- Locations
- 🇷🇺
ECO-Safety, Sankt-Peterburg, Russian Federation
A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 50
- Registration Number
- NCT04036526
- Locations
- 🇷🇺
Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow, Russian Federation
A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
- First Posted Date
- 2019-07-26
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 224
- Registration Number
- NCT04034290
- Locations
- 🇷🇺
Federal state budgetary institution " Main military clinical hospital named after academician N. N. Burdenko " of the Ministry of Defence of the Russian Federation, Moscow, Russian Federation
Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 180
- Registration Number
- NCT03878004
- Locations
- 🇷🇺
"City polyclinic № 2 Of the Department of health of the city of Moscow", Выделите текст, чтобы посмотреть примеры, Moscow, Russian Federation
🇷🇺Sechenov University, Moscow, Russian Federation
The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
- Conditions
- Interventions
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2019-03-15
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 36
- Registration Number
- NCT03651544
- Locations
- 🇷🇺
Federal state budgetary institution " Main military clinical hospital named after academician N. N. Burdenko " of the Ministry of Defence of the Russian Federation, Moscow, Russian Federation
Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
- Conditions
- Interventions
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 777
- Registration Number
- NCT03638830
- Locations
- 🇷🇺
Scientific and Research Center "Eco-Safety", Saint-Petersburg, Russian Federation
🇷🇺Baltic Medicine, Saint-Petersburg, Russian Federation
🇷🇺Road Clinical Hospital of Open Joint Stock Company "Russian Railways, Saint Petersburg, Russian Federation
An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2019-11-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 25
- Registration Number
- NCT03428347
- Locations
- 🇷🇺
Research Institute of Influenza, Sankt-Peterburg, Russian Federation